Programmed Death-1+ T Cells and Regulatory T Cells Are Enriched in Tumor-Involved Lymph Nodes and Associated with Aggressive Features in Papillary Thyroid Cancer
- 1 June 2012
- journal article
- other
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 97 (6), E934-E943
- https://doi.org/10.1210/jc.2011-3428
Abstract
Context: Recurrent metastatic lymph node (LN) disease is common in patients with papillary thyroid cancer (PTC). Novel prognostic markers may be helpful in guiding a therapeutic approach. Our previous studies revealed that immune suppression is evident in PTC and associated with more severe disease. Objective: To characterize the immune response to metastatic PTC, we assessed CD4+ T cell polarization in LN. In addition, we investigated the role of programmed death-1 (PD-1) and T cell exhaustion. Design: Uninvolved (UILN) and tumor-involved lymph nodes (TILN) were sampled ex vivo by fine-needle biopsy. T cell subsets were identified by flow cytometry. In parallel, archived TILN specimens were characterized by immunofluorescence. Setting: The study was conducted at the University of Colorado Hospital. Patients: Data were collected on 94 LN from 19 patients with PTC undergoing neck dissection. Main Outcome: T cell subset frequencies were compared in UILN and TILN and assessed for correlation with recurrent disease and extranodal invasion. Results: Regulatory CD4+ T cells (Treg) were enriched in TILN compared with UILN and further elevated in TILN from patients with recurrent disease. PD-1+ T cells were present at high frequency in TILN and markedly enriched in TILN that showed evidence of extranodal invasion. In TILN, Treg frequency correlated with PD-1+ T cell frequencies. Although PD-1+ T cells produced interferon-γ, they failed to fully down-regulate CD27 and were not actively proliferating. Conclusions: Increased Treg and PD-1+ T cell frequencies in LN may be indicative of aggressive recurrent PTC. Future prospective studies are necessary to determine the prognostic and therapeutic value of these findings in PTC.Keywords
This publication has 36 references indexed in Scilit:
- Early T Cell Signalling Is Reversibly Altered in PD-1+ T Lymphocytes Infiltrating Human TumorsPLOS ONE, 2011
- Endogenous T Cell Responses to Antigens Expressed in Lung Adenocarcinomas Delay Malignant Tumor ProgressionCancer Cell, 2011
- Tumor-Associated Lymphocytes and Increased FoxP3+ Regulatory T Cell Frequency Correlate with More Aggressive Papillary Thyroid CancerJournal of Clinical Endocrinology & Metabolism, 2010
- Tumor-infiltrating NY-ESO-1–specific CD8 + T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancerProceedings of the National Academy of Sciences of the United States of America, 2010
- Features of responding T cells in cancer and chronic infectionCurrent Opinion in Immunology, 2010
- Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impairedBlood, 2009
- Human prostate‐infiltrating CD8+ T lymphocytes are oligoclonal and PD‐1+The Prostate, 2009
- CD4 T cells: fates, functions, and faultsBlood, 2008
- FOXP3+ Tregs and B7-H1+/PD-1+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapyBMC Cancer, 2008
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006